Cahaba Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$919K Buy
3,654
+37
+1% +$7.96K 0.06% 66
2026
Q1
$787K Buy
3,617
+13
+0.4% +$2.88K 0.05% 67
2025
Q4
$824K Buy
3,604
+90
+3% +$20.5K 0.06% 64
2025
Q3
$814K Sell
3,514
-10
-0.3% -$2.04K 0.06% 65
2025
Q2
$654K Buy
3,524
+70
+2% +$13K 0.05% 74
2025
Q1
$724K Sell
3,454
-46
-1% -$8.94K 0.06% 69
2024
Q4
$622K Buy
3,500
+233
+7% +$42.8K 0.05% 81
2024
Q3
$645K Buy
3,267
+9
+0.3% +$1.68K 0.05% 79
2024
Q2
$559K Buy
3,258
+10
+0.3% +$1.66K 0.05% 82
2024
Q1
$591K Sell
3,248
-4
-0.1% -$689 0.05% 76
2023
Q4
$504K Sell
3,252
-796
-20% -$116K 0.05% 80
2023
Q3
$603K Sell
4,048
-183
-4% -$26.9K 0.07% 71
2023
Q2
$570K Buy
4,231
+1,736
+70% +$255K 0.06% 71
2023
Q1
$398K Buy
2,495
+7
+0.3% +$1.07K 0.05% 91
2022
Q4
$402K Sell
2,488
-46
-2% -$7.05K 0.05% 87
2022
Q3
$340K Sell
2,534
-3
-0.1% -$430 0.05% 93
2022
Q2
$388K Buy
2,537
+10
+0.4% +$1.53K 0.06% 87
2022
Q1
$371K Buy
2,527
+757
+43% +$110K 0.05% 96
2021
Q4
$240K Buy
+1,770
New +$209K 0.03% 133

Other funds holding ABBV

Cahaba Wealth Management's ABBV Position: Q2 2026 in Review

Cahaba Wealth Management increased its AbbVie (ABBV) stake by 1% in Q2 2026, buying an estimated $7.96K and bringing the position to 3,654 shares worth $919K. The position accounts for 0.06% of the portfolio, ranked #66.

Cahaba Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cahaba Wealth Management held 3,654 shares of AbbVie worth $919K as of Q2 2026.
  • Cahaba Wealth Management bought 37 AbbVie shares in Q2 2026, an estimated $7.96K.
  • AbbVie made up 0.06% of Cahaba Wealth Management's portfolio in Q2 2026, its #66 holding.
  • Cahaba Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cahaba Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.